Skip to main content

Table 1 Cohort characteristics

From: Intestinal microbiota in pediatric patients with end stage renal disease: a Midwest Pediatric Nephrology Consortium study

 

Control

ESRD-HD

ESRD-PD

Transplant

N (blood/stool)

13/11

8/7

8/7

10/9

Sex (male:female)

6:7

5:3

4:4

10:0

Age (years)

9.5 (3–16)

13.6 (8–17)

11.9 (3-17)

13.2 (2–18)

BMI (kg/m2)

23.15 (14.9–53)

22.1 (16.6–28)

17.8 (14.8–23.4)

18.8 (15.3–23.8)

Time on dialysis (months)

N/A

23.3 (2–77)

21.5 (3–49)

N/A

Kt/v

N/A

1.8 (1.22–2.7)

2.2 (1.89–2.5)

N/A

Time from transplant (month)

N/A

N/A

N/A

43.1 (10–110)

BUN (mg/dl)

13.54 (8–19)

51.00 (33–125)

41.38 (14–65)

17.78 (9–26)

Serum creatinine (mg/dl)

0.37 (0.10–0.70)

8.58 (0.90–18.10)

11.70 (7.40–19.00)

0.99 (0.50–1.60)

eGFR

118 (85-139)

<15

<15

78 (61–108)

  1. ESRD-HD end-stage renal disease on hemodialysis, ESRD-PD end-stage renal disease on peritoneal dialysis, N/A not available, N number of samples, Kt/v dialysis dose, BUN blood urea nitrogen, eGFR estimated glomerular filtration rate